On March 16, 2021, Solid Biosciences joined PPMD for a webinar to provide a safety and efficacy update on the ongoing IGNITE DMD phase I/II clinical study of SGT-001 microdystrophin gene therapy in patients with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 4 years ago You may also like 58:15 Webinar: Psychosocial Considerations for Women in Duchenne (September 2022) 2 years ago Care Webinars,Webinars 1:00:00 Webinar: Medical Management of Women & Carriers (September 2022) 2 years ago Care Webinars,Webinars 1:06:21 Webinar: SRP-9001 Data Update from Studies 101, 102, and 103 (August 2022) 2 years ago Research & Clinical Trial Webinars,Webinars 46:05 Webinar: Casimir’s Duchenne Video Assessment (DVA) ARISE Study (August 2022) 2 years ago Research & Clinical Trial Webinars,Webinars 42:17 Webinar: Dyne Therapeutics Update on DYNE-251 (July 2022) 2 years ago Research & Clinical Trial Webinars,Webinars 1:02:42 Connect with the Experts: Pain Management (August 2022) 2 years ago Care Webinars,Webinars 53:15 Webinar: Twice Weekly Steroids & Exercise – Study Update and Preliminary Findings (April 2022) 3 years ago Research & Clinical Trial Webinars,Webinars 59:37 Webinar: Carrier Cardiac Care (March 2022) 3 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars «1…45678…25»Page 6 of 25
by: Parent Project Muscular Dystrophy
